Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for romidepsin (compound)
Most Correlated Studies
- Breast adenocarcinoma MCF7 cells treated with S2101, UNC0638, GSK343, romidepsin and decitabine
- HCT116 colorectal carcinoma cells treated with HDAC inhibitors largazole, SAHA, and FK228
- Peripheral blood mononuclear cells of cutaneous T-cell lymphoma patients treated with romidepsin
- Colorectal cancer YB5 cells treated with S2101, UNC0638, GSK343, romidepsin and decitabine
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Most Relevant Literature
- Safety and efficacy of tenalisib in combination with romidepsin in patients with relapsed/refractory…
- Improving gastrointestinal quality of life: romidepsin to tucidinostat in a case of angioimmunoblast…
- Romidepsin antagonism with CHOEP.
- Multicenter phase 2 study of romidepsin plus lenalidomide for previously untreated peripheral T-cell…
- Pyroptosis Tuning in Intestinal Cryptosporidiosis via the Natural Histone Deacetylase Inhibitor Romi…
Most Relevant Clinical Trials
- Romidepsin Versus Combination of Romidepsin Plus Pralatrexate in PTCL
- Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies
- Long-term Use of Romidepsin in Patients With CTCL
- Study of Pomalidomide, Dexamethasone, and Romidepsin for Rel/Ref Myeloma
- Romidepsin Plus Oral 5-Azacitidine in Relapsed/Refractory Lymphoid Malignancies
